Page last updated: 2024-08-23

substance p and Diffuse Myofascial Pain Syndrome

substance p has been researched along with Diffuse Myofascial Pain Syndrome in 41 studies

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-19906 (14.63)18.7374
1990's11 (26.83)18.2507
2000's15 (36.59)29.6817
2010's8 (19.51)24.3611
2020's1 (2.44)2.80

Authors

AuthorsStudies
Chang, CT; Chang, KV; Chen, CC; Chu, YC; Han, DS; Lee, CH; Li, MH; Lin, SH; Shieh, YD; Wang, JL1
Akcay, F; Karatay, S; Okur, SC; Uzkeser, H; Yildirim, K1
Björkegren, K; Burell, G; Karlsson, B; Kristiansson, P; Nyberg, F; Svärdsudd, K1
Chen, CC; Han, DS; Lee, CH; Shieh, YD1
Freitag, K; Freitag, MSC; Izquierdo, MDC; Pipis, H; Theoharides, TC; Tsilioni, I1
Andersen, ML; Araujo, P; Frange, C; Hachul, H; Hirotsu, C; Tufik, S1
Gleason, RM; Russell, IJ; Stewart, JM; Theoharides, TC; Tsilioni, I1
da Costa, ED; Paiva, ES; Scheinberg, M1
Brezinschek, HP1
Arshad, M; Arshad, N; Iqbal, R; Mughal, MS1
Cohen, M; Lyon, P; Quintner, J1
Russell, IJ3
Fiebich, B; Haus, U; Müller, W; Stratz, T1
Akyol, O; Ozgocmen, S; Ozyurt, H; Sogut, S1
Jonas, C1
Cheng, TO1
Eichling, PS; Sahni, J1
Peterson, EL1
Gendreau, JF; Kranzler, JD; Rao, SG1
Spaeth, M; Staud, R1
Felder, M1
Bennett, RM2
Houvenagel, E1
Alboukrek, D; Littman, B; Lopez, Y; MacKillip, F; Michalek, JE; Orr, MD; Russell, IJ; Vipraio, GA1
Franke, S; Hein, G; Kluge, H; Sprott, H1
Alarcón, GS; Bradley, LA; Gay, RE; Gay, S; Mussell, HG; Oh, SJ; Sprott, H; Tseng, A; Wintersberger, W1
Eneroth, P; Evengard, B; Fredrikson, S; Henriksson, KG; Lindh, G; Lindquist, L; Nilsson, CG; Terenius, L1
Pierau, FK; Sann, H1
Ackenheil, M; Bondy, B; Müller-Bardorff, H; Pongratz, DE; Schwarz, MJ; Späth, M1
Alarcón, GS; Bradley, LA1
Rau, CL; Russell, IJ1
Bragee, B; Liu, Z; Nyberg, F; Welin, M1
Biasi, G; De Stefano, R; Franceschini, E; Frati, E; Manganelli, S; Marcolongo, R; Selvi, E; Villanova, M1
Kopp, S1
Førre, Ø; Helle, R; Kåss, E; Terenius, L; Vaerøy, H1
Chiu, B; Inman, RD; Reynolds, WJ1
Førre, O; Helle, R; Kåss, E; Terenius, L; Vaeroy, H1
Førre, O; Kåss, E; Sakurada, T; Terenius, L; Vaerøy, H1

Reviews

19 review(s) available for substance p and Diffuse Myofascial Pain Syndrome

ArticleYear
Fibromyalgia and sleep in animal models: a current overview and future directions.
    Current pain and headache reports, 2014, Volume: 18, Issue:8

    Topics: Animals; Chronic Pain; Disease Models, Animal; Evidence-Based Medicine; Fatigue; Fibromyalgia; Humans; Pain Threshold; Rats; Serotonin; Severity of Illness Index; Sleep; Sleep Wake Disorders; Substance P

2014
Fibromyalgia: an update and immunological aspects.
    Current pain and headache reports, 2008, Volume: 12, Issue:5

    Topics: Antibodies; Autoantibodies; Chronic Disease; Evoked Potentials, Somatosensory; Fibromyalgia; Headache; Humans; Interleukin-2; Neural Pathways; Nociceptors; Pain Threshold; Polymers; Posterior Horn Cells; Psychophysiologic Disorders; Substance P

2008
[Mechanisms of muscle pain : significance of trigger points and tender points].
    Zeitschrift fur Rheumatologie, 2008, Volume: 67, Issue:8

    Topics: Connective Tissue; Diagnosis, Differential; Fibromyalgia; Humans; Inflammation Mediators; Muscle, Skeletal; Myofascial Pain Syndromes; Pain, Referred; Palpation; Substance P

2008
Pathophysiology and antioxidant status of patients with fibromyalgia.
    Rheumatology international, 2011, Volume: 31, Issue:2

    Topics: Animals; Antioxidants; Fatigue Syndrome, Chronic; Fibromyalgia; Humans; Hypothalamo-Hypophyseal System; Mice; Oxidative Stress; Pain; Pituitary-Adrenal System; Reactive Nitrogen Species; Reactive Oxygen Species; Substance P

2011
An evolutionary stress-response hypothesis for chronic widespread pain (fibromyalgia syndrome).
    Pain medicine (Malden, Mass.), 2011, Volume: 12, Issue:8

    Topics: Animals; Biological Evolution; Central Nervous System Sensitization; Chronic Pain; Fibromyalgia; Humans; Nociception; Receptors, Neurokinin-1; Stress, Psychological; Substance P

2011
The promise of substance P inhibitors in fibromyalgia.
    Rheumatic diseases clinics of North America, 2002, Volume: 28, Issue:2

    Topics: Benzene Derivatives; Fibromyalgia; Humans; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Substance P

2002
Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide.
    Rheumatology international, 2006, Volume: 26, Issue:7

    Topics: Antioxidants; Autonomic Nervous System; Cerebrovascular Circulation; Cytokines; Diet; Fatigue Syndrome, Chronic; Fibromyalgia; Genetic Predisposition to Disease; Humans; Hypothalamo-Hypophyseal System; Muscles; Nitric Oxide; Oxidative Stress; Pituitary-Adrenal System; Regional Blood Flow; Substance P

2006
Menopause related sleep disorders.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2005, Jul-15, Volume: 1, Issue:3

    Topics: Depression; Estrogen Replacement Therapy; Estrogens; Female; Fibromyalgia; Humans; Hydrocortisone; Melatonin; Menopause; Phytotherapy; Polysomnography; Progesterone; Serotonin; Sleep Apnea Syndromes; Sleep Initiation and Maintenance Disorders; Sleep Stages; Substance P; Testosterone

2005
Fibromyalgia--management of a misunderstood disorder.
    Journal of the American Academy of Nurse Practitioners, 2007, Volume: 19, Issue:7

    Topics: Anticonvulsants; Antidepressive Agents; Causality; Chronic Disease; Diagnosis, Differential; Exercise; Fibromyalgia; Humans; Hypothalamo-Hypophyseal System; Medical History Taking; Neuromuscular Agents; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Care Planning; Patient Education as Topic; Physical Examination; Pituitary-Adrenal System; Primary Health Care; Serotonin; Social Support; Substance P; United States

2007
Understanding the fibromyalgia syndrome.
    Psychopharmacology bulletin, 2007, Volume: 40, Issue:4

    Topics: Animals; Chronic Pain; Fibromyalgia; Humans; Hypothalamo-Hypophyseal System; Neuroimaging; Pituitary-Adrenal System; Serotonin; Substance P; Syndrome

2007
Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia.
    CNS spectrums, 2008, Volume: 13, Issue:3 Suppl 5

    Topics: Afferent Pathways; Brain; Fibromyalgia; Humans; Hyperalgesia; Hypothalamo-Hypophyseal System; Nerve Fibers, Unmyelinated; Nerve Growth Factor; Neuronal Plasticity; Neurotransmitter Agents; Pain Threshold; Peripheral Nerves; Pituitary-Adrenal System; Recruitment, Neurophysiological; Serotonin; Substance P

2008
[The fibrositis syndrome (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1980, Feb-05, Volume: 69, Issue:5

    Topics: Adult; Behavior Therapy; Chlorpromazine; Edema; Endorphins; Female; Fibromyalgia; Humans; Male; Middle Aged; Neurotic Disorders; Obesity; Pain; Pain Management; Sleep Wake Disorders; Substance P; Syndrome; Tryptophan

1980
[Fibromyalgia: pathogenic concepts].
    Revue du rhumatisme (Ed. francaise : 1993), 1993, Volume: 60, Issue:3

    Topics: Enkephalins; Fibromyalgia; Humans; Hypothyroidism; Mental Disorders; Neurotransmitter Agents; Pain Measurement; Serotonin; Sleep Wake Disorders; Substance P

1993
Fibromyalgia and the facts. Sense or nonsense.
    Rheumatic diseases clinics of North America, 1993, Volume: 19, Issue:1

    Topics: Affect; Fibromyalgia; Humans; Muscles; Neurosecretory Systems; Nociceptors; Pain Threshold; Physical Exertion; Stress, Physiological; Substance P

1993
Advances in fibromyalgia: possible role for central neurochemicals.
    The American journal of the medical sciences, 1998, Volume: 315, Issue:6

    Topics: Analgesia; Animals; Calcitonin Gene-Related Peptide; Dynorphins; Fibromyalgia; Humans; Hyperalgesia; Neurotransmitter Agents; Serotonin; Substance P

1998
Efferent functions of C-fiber nociceptors.
    Zeitschrift fur Rheumatologie, 1998, Volume: 57 Suppl 2

    Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Efferent Pathways; Fibromyalgia; Humans; Inflammation; Nerve Fibers; Neurokinin A; Nociceptors; Skin; Substance P; Swine

1998
Neurochemical pathogenesis of fibromyalgia.
    Zeitschrift fur Rheumatologie, 1998, Volume: 57 Suppl 2

    Topics: Animals; Fibromyalgia; Humans; Neurotransmitter Agents; Nociceptors; Pain Threshold; Serotonin; Substance P

1998
Is fibromyalgia a distinct clinical syndrome?
    Current review of pain, 2000, Volume: 4, Issue:4

    Topics: Autonomic Nervous System; Chronic Disease; Demography; Fibromyalgia; Humans; Neurologic Examination; Neurosecretory Systems; Nociceptors; Pain; Pain Threshold; Spinal Cord; Substance P

2000
Neuroendocrine, immune, and local responses related to temporomandibular disorders.
    Journal of orofacial pain, 2001,Winter, Volume: 15, Issue:1

    Topics: Arthritis; Calcitonin Gene-Related Peptide; Dinoprostone; Facial Pain; Fibromyalgia; Humans; Hyperalgesia; Inflammation Mediators; Interleukin-1; Leukotriene B4; Masseter Muscle; Neuroimmunomodulation; Neuropeptide Y; Neuropeptides; Neurosecretory Systems; Open Bite; Serotonin; Substance P; Synovial Fluid; Temporomandibular Joint Disorders; Tumor Necrosis Factor-alpha

2001

Trials

3 trial(s) available for substance p and Diffuse Myofascial Pain Syndrome

ArticleYear
Effects of Acupuncture Treatment on Fibromyalgia Symptoms, Serotonin, and Substance P Levels: A Randomized Sham and Placebo-Controlled Clinical Trial.
    Pain medicine (Malden, Mass.), 2018, 03-01, Volume: 19, Issue:3

    Topics: Acupuncture Therapy; Adult; Female; Fibromyalgia; Humans; Middle Aged; Pain Management; Pain Measurement; Serotonin; Substance P; Treatment Outcome; Young Adult

2018
Decline of substance P levels after stress management with cognitive behaviour therapy in women with the fibromyalgia syndrome.
    Scandinavian journal of pain, 2019, 07-26, Volume: 19, Issue:3

    Topics: Cognitive Behavioral Therapy; Female; Fibromyalgia; Humans; Middle Aged; Pain; Psychometrics; Substance P; Surveys and Questionnaires

2019
Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome.
    Arthritis and rheumatism, 1994, Volume: 37, Issue:11

    Topics: Adult; Female; Fibromyalgia; Humans; Male; Middle Aged; Predictive Value of Tests; Radioimmunoassay; Regression Analysis; Spinal Puncture; Substance P

1994

Other Studies

19 other study(ies) available for substance p and Diffuse Myofascial Pain Syndrome

ArticleYear
A role for substance P and acid-sensing ion channel 1a in prolotherapy with dextrose-mediated analgesia in a mouse model of chronic muscle pain.
    Pain, 2022, 05-01, Volume: 163, Issue:5

    Topics: Acid Sensing Ion Channels; Analgesia; Animals; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibromyalgia; Glucose; Hyperalgesia; Mice; Myalgia; Prolotherapy; Substance P

2022
Involvement of Substance P in the Analgesic Effect of Low-Level Laser Therapy in a Mouse Model of Chronic Widespread Muscle Pain.
    Pain medicine (Malden, Mass.), 2019, 10-01, Volume: 20, Issue:10

    Topics: Acids; Animals; Capsaicin; Chronic Pain; Cnidarian Venoms; Disease Models, Animal; Dose-Response Relationship, Drug; Fibromyalgia; Laser Therapy; Low-Level Light Therapy; Mice; Mice, Inbred C57BL; Mice, Knockout; Musculoskeletal Pain; Protein Precursors; Signal Transduction; Substance P; Tachykinins; TRPV Cation Channels

2019
Effects of an Extract of Salmon Milt on Symptoms and Serum TNF and Substance P in Patients With Fibromyalgia Syndrome.
    Clinical therapeutics, 2019, Volume: 41, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Dietary Supplements; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Salmon; Semen; Substance P; Tumor Necrosis Factor-alpha; Young Adult

2019
Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.
    The Journal of pharmacology and experimental therapeutics, 2016, Volume: 356, Issue:3

    Topics: Adult; Aged; Biomarkers; Corticotropin-Releasing Hormone; Cytokines; Female; Fibromyalgia; Humans; Inflammation Mediators; Interleukin-6; Male; Mast Cells; Middle Aged; Substance P; Tachykinins; Tumor Necrosis Factor-alpha

2016
Influence of tropisetron on the serum substance P levels in fibromyalgia patients.
    Scandinavian journal of rheumatology. Supplement, 2004, Volume: 119

    Topics: Female; Fibromyalgia; Humans; Indoles; Middle Aged; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Substance P; Time Factors; Tropisetron

2004
[Fibromyalgia: rheumatologic or psychiatric disease?].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:11 Pt 2

    Topics: Adult; Anxiety Disorders; Child; Diagnosis, Differential; Fibromyalgia; Genetic Predisposition to Disease; Humans; Mental Disorders; Prevalence; Risk Factors; Somatoform Disorders; Stress Disorders, Post-Traumatic; Substance P

2006
Acupuncture treatment for musculoskeletal chest pain.
    International journal of cardiology, 2007, Sep-14, Volume: 121, Issue:1

    Topics: Acupuncture Therapy; Chest Pain; Fibromyalgia; Humans; Keratan Sulfate; Osteoarthritis; Serotonin; Substance P

2007
Fibrositis: misnomer for a common rheumatic disorder.
    The Western journal of medicine, 1981, Volume: 134, Issue:5

    Topics: Diagnosis, Differential; Enkephalins; Fatigue; Fibromyalgia; Humans; Rheumatic Diseases; Substance P; Terminology as Topic

1981
Pain treatment of fibromyalgia by acupuncture.
    Rheumatology international, 1998, Volume: 18, Issue:1

    Topics: Acupuncture Therapy; Biomarkers; Blood Platelets; Chronic Disease; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Pain Management; Pain Measurement; Platelet Count; Serotonin; Substance P; Treatment Outcome

1998
Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue.
    Arthritis and rheumatism, 1998, Volume: 41, Issue:9

    Topics: Adult; Aged; DNA Primers; Female; Fibromyalgia; Galanin; Humans; Immunoenzyme Techniques; Male; Middle Aged; Muscle, Skeletal; Neuropeptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Polymerase Chain Reaction; RNA, Messenger; Secretogranin II; Serotonin; Substance P

1998
Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome.
    Pain, 1998, Volume: 78, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Fatigue Syndrome, Chronic; Female; Fibromyalgia; Humans; Male; Reference Values; Substance P

1998
Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients.
    Neuroscience letters, 1999, Jan-15, Volume: 259, Issue:3

    Topics: Adult; Biomarkers; Female; Fibromyalgia; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Pain; Sleep; Substance P; Tryptophan

1999
Is Chiari malformation associated with increased levels of substance P and clinical symptoms in persons with fibromyalgia?
    Arthritis and rheumatism, 1999, Volume: 42, Issue:12

    Topics: Arnold-Chiari Malformation; Fibromyalgia; Humans; Substance P

1999
A high-recovery extraction procedure for quantitative analysis of substance P and opioid peptides in human cerebrospinal fluid.
    Peptides, 2000, Volume: 21, Issue:6

    Topics: Fibromyalgia; Humans; Opioid Peptides; Radioimmunoassay; Reproducibility of Results; Sensitivity and Specificity; Substance P

2000
Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofascial pain syndrome.
    The Journal of rheumatology, 2000, Volume: 27, Issue:12

    Topics: Adult; Analysis of Variance; Female; Fibromyalgia; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Middle Aged; Muscle, Skeletal; Myofascial Pain Syndromes; Neurons, Afferent; Substance P

2000
Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis.
    Pain, 1988, Volume: 32, Issue:1

    Topics: Adult; Female; Fibromyalgia; Humans; Raynaud Disease; Smoking; Substance P

1988
Plasma substance P levels in fibrositis.
    The Journal of rheumatology, 1988, Volume: 15, Issue:12

    Topics: Adult; Female; Fibromyalgia; Humans; Male; Middle Aged; Radioimmunoassay; Substance P

1988
Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome).
    The Journal of rheumatology, 1988, Volume: 15, Issue:12

    Topics: Adult; beta-Endorphin; Female; Fibromyalgia; Humans; Middle Aged; Radioimmunoassay; Substance P

1988
Modulation of pain in fibromyalgia (fibrositis syndrome): cerebrospinal fluid (CSF) investigation of pain related neuropeptides with special reference to calcitonin gene related peptide (CGRP).
    The Journal of rheumatology. Supplement, 1989, Volume: 19

    Topics: Calcitonin Gene-Related Peptide; Female; Fibromyalgia; Humans; Neuropeptides; Pain; Palliative Care; Peptide Fragments; Radioimmunoassay; Substance P

1989